Cargando…
Novel and Controversial Therapies in COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931150/ https://www.ncbi.nlm.nih.gov/pubmed/33717367 http://dx.doi.org/10.2174/1874306402014010079 |
_version_ | 1783660234703634432 |
---|---|
author | Singh, Romil Shaik, Likhita Mehra, Ishita Kashyap, Rahul Surani, Salim |
author_facet | Singh, Romil Shaik, Likhita Mehra, Ishita Kashyap, Rahul Surani, Salim |
author_sort | Singh, Romil |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19. |
format | Online Article Text |
id | pubmed-7931150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-79311502021-03-12 Novel and Controversial Therapies in COVID-19 Singh, Romil Shaik, Likhita Mehra, Ishita Kashyap, Rahul Surani, Salim Open Respir Med J Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19. Bentham Science Publishers 2020-12-31 /pmc/articles/PMC7931150/ /pubmed/33717367 http://dx.doi.org/10.2174/1874306402014010079 Text en © 2020 Singh et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Singh, Romil Shaik, Likhita Mehra, Ishita Kashyap, Rahul Surani, Salim Novel and Controversial Therapies in COVID-19 |
title | Novel and Controversial Therapies in COVID-19 |
title_full | Novel and Controversial Therapies in COVID-19 |
title_fullStr | Novel and Controversial Therapies in COVID-19 |
title_full_unstemmed | Novel and Controversial Therapies in COVID-19 |
title_short | Novel and Controversial Therapies in COVID-19 |
title_sort | novel and controversial therapies in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931150/ https://www.ncbi.nlm.nih.gov/pubmed/33717367 http://dx.doi.org/10.2174/1874306402014010079 |
work_keys_str_mv | AT singhromil novelandcontroversialtherapiesincovid19 AT shaiklikhita novelandcontroversialtherapiesincovid19 AT mehraishita novelandcontroversialtherapiesincovid19 AT kashyaprahul novelandcontroversialtherapiesincovid19 AT suranisalim novelandcontroversialtherapiesincovid19 |